Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2025 08:00 ET | Source: Curonix LLC

Curonix Unveils NervPulse™ Therapy: Setting a New Standard in Nerve-Specific Peripheral Nerve Stimulation (PNS) Therapy

Curonix LLC proudly introduces NervPulseTherapy, an advanced, evidence-based programming platform designed to optimize peripheral nerve stimulation.
December 04, 2024 08:00 ET | Source: Curonix LLC

Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines for the Management of Chronic Pain

Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines
July 09, 2024 08:00 ET | Source: Curonix LLC

Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System

Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System.
June 23, 2024 10:00 ET | Source: SPR Therapeutics, Inc.

SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row

Medical Device Leader SPR Therapeutics again named a Top Workplace in Northeast Ohio
January 18, 2024 08:00 ET | Source: Curonix LLC

Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence

Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
December 12, 2023 11:48 ET | Source: SPR Therapeutics, Inc.

SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT® PNS System for Low Back Pain

SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT PNS System for Low Back Pain
November 01, 2023 09:00 ET | Source: Curonix LLC

Curonix Celebrates 1st Anniversary

POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary. In November 2022, Curonix completed the...
June 07, 2023 07:00 ET | Source: Curonix LLC

Independent clinical study shows Curonix’s Freedom® PNS System significantly reduces pain scores and medication usage

POMPANO BEACH, Fla., June 07, 2023 (GLOBE NEWSWIRE) -- Curonix LLC, a medical technology company dedicated to freeing patients from chronic pain, announced the publication of 24 months of data from...
May 17, 2023 10:16 ET | Source: SPR Therapeutics, Inc.

Real-World Data from Over 6,100 Patients Corroborates Significant Pain Reduction from Prior Prospective Studies for Patients Treated with SPRINT® PNS

CLEVELAND, May 17, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics announced the publication of a comprehensive real-world retrospective data analysis of over 6,100 patients demonstrating significant...
March 16, 2023 08:00 ET | Source: SPR Therapeutics, Inc.

SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference

CLEVELAND, March 16, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients suffering from acute or...

Next Page keyboard_arrow_right